Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke
- PMID: 25123217
- PMCID: PMC4346099
- DOI: 10.1161/STROKEAHA.114.006072
Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke
Abstract
Background and purpose: Atrial fibrillation (AF) is prevalent and there is a clinical need for biomarkers to identify individuals at higher risk for AF. Fixed throughout a life course and assayable early in life, genetic biomarkers may meet this need. Here, we investigate whether multiple single nucleotide polymorphisms together as an AF genetic risk score (AF-GRS) can improve prediction of one's risk for AF.
Methods: In 27 471 participants of the Malmö Diet and Cancer Study, a prospective, community-based cohort, we used Cox models that adjusted for established AF risk factors to assess the association of AF-GRS with incident AF and ischemic stroke. Median follow-up was 14.4 years for incident AF and 14.5 years for ischemic stroke. The AF-GRS comprised 12 single nucleotide polymorphisms that had been previously shown to be associated with AF at genome-wide significance.
Results: During follow-up, 2160 participants experienced a first AF event and 1495 had a first ischemic stroke event. Participants in the top AF-GRS quintile were at increased risk for incident AF (hazard ratio, 2.00; 95% confidence interval, 1.73-2.31; P=2.7×10(-21)) and ischemic stroke (hazard ratio, 1.23; 95% confidence interval, 1.04-1.46; P=0.02) when compared with the bottom quintile. Addition of the AF-GRS to established AF risk factors modestly improved both discrimination and reclassification (P<0.0001 for both).
Conclusions: An AF-GRS can identify 20% of individuals who are at ≈2-fold increased risk for incident AF and at 23% increased risk for ischemic stroke. Targeting diagnostic or therapeutic interventions to this subset may prove clinically useful.
Keywords: atrial fibrillation; polymorphism, single nucleotide; stroke.
© 2014 American Heart Association, Inc.
Figures
Similar articles
-
C-reactive protein gene polymorphism predicts the risk of thromboembolic stroke in patients with atrial fibrillation: a more than 10-year prospective follow-up study.J Thromb Haemost. 2017 Aug;15(8):1541-1546. doi: 10.1111/jth.13735. Epub 2017 Jul 14. J Thromb Haemost. 2017. PMID: 28498565
-
Atrial Fibrillation Genetic Risk and Ischemic Stroke Mechanisms.Stroke. 2017 Jun;48(6):1451-1456. doi: 10.1161/STROKEAHA.116.016198. Epub 2017 May 3. Stroke. 2017. PMID: 28468926 Free PMC article.
-
Multilocus genetic risk score associates with ischemic stroke in case-control and prospective cohort studies.Stroke. 2014 Feb;45(2):394-402. doi: 10.1161/STROKEAHA.113.002938. Epub 2014 Jan 16. Stroke. 2014. PMID: 24436234 Free PMC article.
-
GWAS contribution to atrial fibrillation and atrial fibrillation-related stroke: pathophysiological implications.Pharmacogenomics. 2019 Jul;20(10):765-780. doi: 10.2217/pgs-2019-0054. Epub 2019 Aug 1. Pharmacogenomics. 2019. PMID: 31368859 Review.
-
Genomics of Atrial Fibrillation.Curr Cardiol Rep. 2016 Jun;18(6):55. doi: 10.1007/s11886-016-0735-8. Curr Cardiol Rep. 2016. PMID: 27139902 Free PMC article. Review.
Cited by
-
The Inclusion of Underrepresented Populations in Cardiovascular Genetics and Epidemiology.J Cardiovasc Dev Dis. 2024 Feb 5;11(2):56. doi: 10.3390/jcdd11020056. J Cardiovasc Dev Dis. 2024. PMID: 38392270 Free PMC article. Review.
-
Assessment Timings of Polygenic Risk Score for Atherosclerotic Cardiovascular Disease.J Atheroscler Thromb. 2024 Jul 1;31(7):1029-1030. doi: 10.5551/jat.ED254. Epub 2024 Feb 17. J Atheroscler Thromb. 2024. PMID: 38369334 Free PMC article. No abstract available.
-
Clinical and Genetic Atrial Fibrillation Risk and Discrimination of Cardioembolic From Noncardioembolic Stroke.Stroke. 2023 Jul;54(7):1777-1785. doi: 10.1161/STROKEAHA.122.041533. Epub 2023 Jun 26. Stroke. 2023. PMID: 37363945 Free PMC article.
-
Genome and atrial fibrillation.J Arrhythm. 2023 Apr 19;39(3):303-309. doi: 10.1002/joa3.12847. eCollection 2023 Jun. J Arrhythm. 2023. PMID: 37324776 Free PMC article. Review.
-
Integrating polygenic and clinical risks to improve stroke risk stratification in prospective Chinese cohorts.Sci China Life Sci. 2023 Jul;66(7):1626-1635. doi: 10.1007/s11427-022-2280-3. Epub 2023 Mar 3. Sci China Life Sci. 2023. PMID: 36881318
References
-
- Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in AF (ATRIA) Study. JAMA. 2001;285:2370–2375. - PubMed
-
- Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009;104:1534–1539. - PubMed
-
- Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27:949–953. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical